Metabolic Effects of Antipsychotic Treatment: Between a Rock and a Hard Place?

Green AI Patel JK Goisman RM Allison DB Blackburn G. Weight gain from novel antipsychotic drugs: Need for action. Gen Hosp Psychiatry 2000;22:224–35.

Goldman LS . Medical illness in patients with schizophrenia. J Clin Psychiatry 1999;60(suppl 21):10–5.

Osby U Correia N Brandt L Ekbom A Sparen P. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res 2000;45(1–2):21–8.

Meyer J Nasrallah H , Issues surrounding medical care for individuals with schizophrenia. In: Meyer J Nasrallah H , editors. Medical illness and schizophrenia. Washington (DC): Amercian Psychiatric Press; 2003. p 1–13.

Newcomer JW Haupt DW . The metabolic effects of antipsychotic medications. Can J Psychiatry 2006;51:480–91).

Cohn TA Sernyak M. Metabolic monitoring for patients treated with antipsychotic medications. Can J Psychiatry 2006;51:492–501).

Faulkner G Cohn TA . Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbances in patients treated with antipsychotic medications. Can J Psychiatry 2006;51:502–11).

Faulkner G Cohn TA Remington G , Interventions for weight gain in schizophrenia. Protocol for a Cochrane Review. In: The Cochrane Library. Oxford (UK): Update Software. 2005.